Eye Floaters (cont.)
John D. Sheppard, MD, MMSc
David M. Salib, MD
Andrew A. Dahl, MD, FACS
Andrew A. Dahl, MD, FACS
Andrew A. Dahl, MD, is a board-certified ophthalmologist. Dr. Dahl's educational background includes a BA with Honors and Distinction from Wesleyan University, Middletown, CT, and an MD from Cornell University, where he was selected for Alpha Omega Alpha, the national medical honor society. He had an internal medical internship at the New York Hospital/Cornell Medical Center.
IN THIS ARTICLE
When to Seek Medical Care
It is impossible to determine whether or not a new onset floater is benign or pathologic based solely upon the symptoms. Thus patients with new onset floaters should seek the care of their eye-care professional, their ophthalmologist, or optometrist. A visit to an internist, pediatrician, primary-care doctor, urgent-care doctor, emergency-room doctor or other non-eye-care professional is simply inadequate to ascertain a proper diagnosis. Only eye-care professionals have the expensive and complex complement of diagnostic equipment and the expertise to provide a diagnosis. In some instances, health-care plans create barriers to specialists and a referral must be obtained prior to visiting the appropriate eye-care professional. These hurdles must be engaged and overcome.
Patients with a longstanding history of floaters that are familiar in character to the patient need not suddenly panic and seek care unless there is an obvious change in the size, shape, intensity, or density of the floaters. Other alarming symptoms include blurred vision, a red eye, pain in the eye, tenderness, a severe discharge from the eye, photophobia or aversion to bright lights, new onset of flashes, and of course loss of vision.
Some patients have a higher risk for pathologic causation of their floaters and should seek professional care immediately. These at risk patients include those with known retinal diseases, diabetes, previous eye surgery, previous eye trauma, recent eye trauma, previous eye inflammation or uveitis, bleeding disorders, chemotherapy, and anticoagulation therapy. Anticoagulants are commonly used for a wide variety of conditions such as deep vein thrombosis, pulmonary embolism, stroke, heart attack, or coronary stents. Anticoagulant therapy includes warfarin (Coumadin), clopidogrel (Plavix), and aspirin (Bayer).
Patients with arthritis or joint pain from athletic injury very frequently take oral NSAIDs or nonsteroidal anti-inflammatory drugs. These medications thin the blood and may also increase the risk of a vitreous hemorrhage. Many over-the-counter (OTC) cold and sinus medications also include low doses of a NSAID. Just as these medications can cause an increased risk of bruising under the skin, there may be an associated increased risk of vitreous hemorrhage from otherwise benign events. NSAIDs include naproxen (Naprosyn, Aleve), ibuprofen (Motrin), and aspirin.
Must Read Articles Related to Eye Floaters
Get breaking medical news.